Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer.

Front Pharmacol · 2021 · PMC8801920 · PMID 35111055

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

a nonsignificant trendp = 0.064so close (0.05 < p ≤ 0.1)

There was a nonsignificant trend for lower CR in the high titer group than in the non-high titer group at 3 months ( p = 0.064).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.